🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For FreeCopy Portfolio

Europe stocks slide as pharmaceuticals fall; DAX down 0.40%

Published 09/15/2010, 07:54 AM
NDX
-
UK100
-
FCHI
-
DJI
-
DE40
-
STOXX50
-
DBKGn
-
PEUP
-
RENA
-
XTA
-
AZN
-
RIO
-
GSK
-
MS
-
2070
-
Investing.com – European stocks were lower in Wednesday, as pharmaceutical shares fell but declines were limited as auto-makers rallied; meanwhile U.S. futures indexes pointed to a lower open on Wall Street.

During European afternoon trade, the EURO STOXX 50 fell 0.66%; France’s CAC 40 shed 0.61% and Germany's DAX lost 0.40%.

Shares in drug makers AstraZeneca fell 1.40% after news that the U.S. Food and Drug Administration delayed approval for its heart drug Brilinta by 3 months.

Meanwhile, shares in pharmaceutical giant GlaxoSmithKline fell 0.23% after the company's stock was downgraded by Jefferies International, while shares in Germany's Merck fell 1.51%.

Automakers rallied, boosted by Japan's intervention in currency markets. Shares in Renault, which is part owned by Japan's Nissan jumped 3.27%. Elsewhere in the sector, shares in Peugeot Citroen advanced 4.15% after Morgan Stanley upgraded the company's stock.

In the financial sector, shares in Deutsche Bank fell 1.60% and shares in Deutsch Post fell 1.48% after Deutsche Bank announced that it intended to submit a takeover offer for the lender on Monday. 

In London, the commodity heavy FTSE 100 was down as miners underperformed. Shares in Rio Tinto fell 0.90%, while shares in Xstrata tumbled 1.41%.

The outlook for U.S. equity markets, meanwhile, was downbeat: Dow Jones Industrial Average futures indicated a dip of 0.15%, S&P 500 futures pointed to a slide of 0.26% and Nasdaq 100 futures indicated a drop of 0.21%.

Later in the day the U.S. was to release official data on manufacturing and industrial production.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.